Trial Information
Inclusion Criteria:
- women with a new LSIL diagnosis an HPV positivity on PAP smear
Exclusion Criteria:
- women over 65
- immunocompromised patients (because of disease or drugs)
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Outcome Measure:
1.proportion of HPV positives in both arms
Outcome Time Frame:
6months
Safety Issue:
No
Principal Investigator
veronique verhoeven, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Universiteit Antwerpen
Authority:
Belgium: Institutional Review Board
Study ID:
2414VV
NCT ID:
NCT01097356
Start Date:
April 2010
Completion Date:
December 2010
Related Keywords:
- HPV-related Cytological Abnormalities on PAP Smear (LSIL)
- Congenital Abnormalities